Inpex Corporation
Inpex Corporation (IPXHY) Financial Performance & Income Statement Overview
Review Inpex Corporation (IPXHY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Inpex Corporation (IPXHY) Income Statement & Financial Overview
View the income breakdown for Inpex Corporation IPXHY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $536.90B | $518.28B | $556.70B | $594.06B |
| Cost of Revenue | $217.20B | $213.57B | $228.56B | $234.66B |
| Gross Profit | $319.70B | $304.71B | $328.13B | $359.40B |
| Gross Profit Ratio | $0.60 | $0.59 | $0.59 | $0.60 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $1.50B |
| SG&A Expenses | $34.62B | $36.80B | $41.79B | $27.47B |
| Operating Expenses | $34.62B | $51.003B | $39.86B | $39.43B |
| Total Costs & Expenses | $251.82B | $264.57B | $238.69B | $274.09B |
| Interest Income | $31.13B | $36.64B | $30.05B | $48.68B |
| Interest Expense | $19.64B | $39.95B | $12.87B | $28.35B |
| Depreciation & Amortization | $89.81B | $89.81B | $96.59B | $96.59B |
| EBITDA | $378.42B | $333.12B | $397.94B | $389.27B |
| EBITDA Ratio | $0.70 | $0.64 | $0.71 | $0.66 |
| Operating Income | $285.08B | $253.71B | $318.008B | $319.97B |
| Operating Income Ratio | $0.53 | $0.49 | $0.57 | $0.54 |
| Other Income/Expenses (Net) | $50.27B | -$13.71B | $17.19B | $20.32B |
| Income Before Tax | $335.36B | $240.00B | $335.19B | $340.29B |
| Income Before Tax Ratio | $0.62 | $0.46 | $0.60 | $0.57 |
| Income Tax Expense | $200.56B | $119.76B | $242.55B | $252.92B |
| Net Income | $126.29B | $137.92B | $76.84B | $90.76B |
| Net Income Ratio | $0.24 | $0.27 | $0.14 | $0.15 |
| EPS | $105.46 | $115.17 | $63.01 | $72.36 |
| Diluted EPS | $105.38 | $115.17 | $63.01 | $72.31 |
| Weighted Avg Shares Outstanding | $1.20B | $1.20B | $1.22B | $1.25B |
| Weighted Avg Shares Outstanding (Diluted) | $1.20B | $1.20B | $1.22B | $1.26B |
Over the past four quarters, Inpex Corporation demonstrated steady revenue growth, increasing from $594.06B in Q2 2024 to $536.90B in Q1 2025. Operating income reached $285.08B in Q1 2025, maintaining a consistent 53% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $378.42B, reflecting operational efficiency. Net income dropped to $126.29B, with EPS at $105.46. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan